Investors merge Wright with Cremascoli:
This article was originally published in Clinica
Wright Medical, in which Warburg Pincus acquired a majority holding this year, has reached an agreement to merge with fellow orthopaedics company Cremascoli Ortho. Cremascoli Ortho was funded with $39 million in 1997 by Hambro European Ventures. Wright, based in Arlington, Tennessee, is the world's leading manufacturer of foot and hand implants. It also produces knee and hip joints and bone graft materials. Cremascoli Ortho has R&D facilities in Milan, Italy and manufactures in Toulon, France.
You may also be interested in...
“You can’t just live off the brand equity anymore,” warned J&J's Consumer Health's Minoj Raghunandanan during the ‘Advancing Trust in the Self-Care Industry’ webinar co-hosted by the Global Self-Care Federation and HBW Insight. “You’ve got to continue to build that trust between consumers and products day-in day-out.”
After almost a year as CEO of Centrient, Rex Clements reflects on the company’s experiences operating amid a pandemic that has underlined the importance of a diversified supply chain, while also highlighting the firm’s sustainable manufacturing initiatives and calling for non-price criteria to be taken into account by procurement processes, in an exclusive interview with Generics Bulletin.
While it was not as affected as some other countries, Japan still had the pandemic to deal with and regulators responded while managing to keep up regular product review work, including several world-first approvals. Coronavirus vaccine roll-outs and the first general annual reimbursement price cut are on the cards for this year.